BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10079806)

  • 1. The North American experience with photopheresis.
    Zic JA; Miller JL; Stricklin GP; King LE
    Ther Apher; 1999 Feb; 3(1):50-62. PubMed ID: 10079806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell clonality and the effect of photopheresis in systemic sclerosis and graft versus host disease.
    French LE; Rook AH
    Transfus Apher Sci; 2002 Jun; 26(3):191-6. PubMed ID: 12126205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo.
    Holien T; Gederaas OA; Darvekar SR; Christensen E; Peng Q
    Lasers Surg Med; 2018 Jul; 50(5):469-475. PubMed ID: 29460964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photopheresis (extracorporeal photochemotherapy).
    Trautinger F; Just U; Knobler R
    Photochem Photobiol Sci; 2013 Jan; 12(1):22-8. PubMed ID: 22859214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal photochemotherapy.
    Maeda A
    J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal Photopheresis and Its Use in Clinical Dermatology in Canada.
    Lagacé F; Netchiporouk E; Turchin I; Gulliver W; Dutz J; Kirchhof MG; Popradi P; Gniadecki R; Lynde C; Litvinov IV
    Skin Therapy Lett; 2022 Sep; 27(5):1-6. PubMed ID: 36469458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.
    Alfred A; Taylor PC; Dignan F; El-Ghariani K; Griffin J; Gennery AR; Bonney D; Das-Gupta E; Lawson S; Malladi RK; Douglas KW; Maher T; Guest J; Hartlett L; Fisher AJ; Child F; Scarisbrick JJ
    Br J Haematol; 2017 Apr; 177(2):287-310. PubMed ID: 28220931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photochemotherapy induces bona fide immunogenic cell death.
    Tatsuno K; Yamazaki T; Hanlon D; Han P; Robinson E; Sobolev O; Yurter A; Rivera-Molina F; Arshad N; Edelson RL; Galluzzi L
    Cell Death Dis; 2019 Aug; 10(8):578. PubMed ID: 31371700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal photopheresis: technique, established and novel indications.
    Marques MB; Adamski J
    J Clin Apher; 2014 Aug; 29(4):228-34. PubMed ID: 24828404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and buffy coat concentration of 8-methoxypsoralen in patients treated with extracorporeal photopheresis.
    Balogh A; Merkel U; Looks A; Vollandt R; Wollina U
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):397-401. PubMed ID: 9784014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis induction by extracorporeal photopheresis is enhanced by increasing the 8-methoxypsoralen concentration and by replacing plasma with saline.
    Hähnel V; Brosig AM; Ehrenschwender M; Burkhardt R; Offner R; Ahrens N
    Transfusion; 2021 Oct; 61(10):2991-2999. PubMed ID: 34427336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photopheresis: Advances and Use in Systemic Sclerosis.
    Zhou XA; Choi J
    Curr Rheumatol Rep; 2017 Jun; 19(6):31. PubMed ID: 28466383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alternative for extracorporeal photopheresis: 8-methoxypsoralen and UVA-treated leucocytes from allogeneic donors improve graft-versus-host disease in mice.
    Budde H; Papert S; Reichardt HM; Jarry H; Riggert J; Legler TJ
    Vox Sang; 2018 Nov; 113(8):803-810. PubMed ID: 30353554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extracorporeal photopheresis].
    Hsieh A; Cortés B
    Rev Med Suisse; 2018 Mar; 14(600):699-702. PubMed ID: 29589657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracorporeal photopheresis: how, when, and why.
    Ward DM
    J Clin Apher; 2011; 26(5):276-85. PubMed ID: 21898572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug monitoring of orally administered 8-methoxypsoralen in patients treated with extracorporeal photopheresis.
    Balogh A; Merkel U; Looks A; Vollandt R; Wollina U
    Skin Pharmacol Appl Skin Physiol; 1998; 11(4-5):258-65. PubMed ID: 9885410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of 8-methoxypsoralen during extracorporeal photopheresis.
    Shephard SE; Nestle FO; Panizzon R
    Photodermatol Photoimmunol Photomed; 1999 Apr; 15(2):64-74. PubMed ID: 10321518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of extracorporeal photochemotherapy in "non-oncological" diseases.
    Dall'Amico R; Zulian F; Montini G; Andretta B; Murer L; Rossetti F; Livi U; Zacchello G; Zacchello F
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():168-72. PubMed ID: 7912229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal photopheresis as a therapy for autoimmune diseases.
    Kuzmina Z; Stroncek D; Pavletic SZ
    J Clin Apher; 2015 Aug; 30(4):224-37. PubMed ID: 25546289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of 8-methoxypsoralen and ultraviolet a light effects on human stroma generation and function.
    Legitimo A; Consolini R; Bencivelli W; Crimaldi G; Migliaccio P; Mosca F
    Acta Haematol; 2006; 116(3):192-7. PubMed ID: 17016038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.